Consistent with our findings, Yang et al. demonstrated through single-cell sequencing that ITGB1 can suppress the activation of immune T cells by upregulating macrophages and neutrophils, leading to immune escape of pancreatic cancer cells and reduced response rates to immune checkpoint therapy [42]. Here, ITGB1 is linked to familial pancreatic carcinoma.